Artara Therapeutics Inc (TARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,596 | -40,420 | -65,952 | -47,252 | -33,978 |
| Depreciation Amortization | -353 | -103 | 32,268 | 2,904 | 103 |
| Other Working Capital | 5,016 | -3,126 | 539 | -516 | 722 |
| Other Operating Activity | 4,125 | 6,092 | 6,688 | 10,362 | 9,746 |
| Operating Cash Flow | $-35,808 | $-37,557 | $-26,457 | $-34,502 | $-23,407 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -29,382 | -12,186 | -43,550 | -124,748 | N/A |
| PPE Investments | -63 | -45 | -120 | -596 | -884 |
| Sale Of Investment | 48,600 | 65,338 | 58,620 | 27,150 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | 3,719 |
| Investing Cash Flow | $19,155 | $53,107 | $14,950 | $-98,194 | $2,835 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 41,964 | 0 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 11,087 |
| Common Stock Issued | 97,984 | 0 | N/A | N/A | 530 |
| Other Financing Activity | -83 | -91 | -90 | -228 | 177,784 |
| Financing Cash Flow | $139,865 | $-91 | $-90 | $-228 | $189,401 |
| Beginning Cash Position | 40,331 | 24,872 | 36,469 | 169,393 | 564 |
| End Cash Position | 163,543 | 40,331 | 24,872 | 36,469 | 169,393 |
| Net Cash Flow | $123,212 | $15,459 | $-11,597 | $-132,924 | $168,829 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,808 | -37,557 | -26,457 | -34,502 | -23,407 |
| Capital Expenditure | -63 | -45 | -120 | -596 | -884 |
| Free Cash Flow | -35,871 | -37,602 | -26,577 | -35,098 | -24,291 |